Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $161,168 - $179,904
-1,600 Reduced 19.75%
6,500 $675,000
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $225,475 - $276,000
-2,500 Reduced 23.58%
8,100 $891,000
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $152,848 - $183,392
1,600 Added 17.78%
10,600 $1.03 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $242,150 - $285,025
2,500 Added 38.46%
9,000 $911,000
Q1 2022

May 17, 2022

SELL
$114.02 - $139.04 $45,608 - $55,616
-400 Reduced 5.8%
6,500 $769,000
Q1 2021

Nov 12, 2021

BUY
$108.84 - $128.23 $511,548 - $602,681
4,700 Added 213.64%
6,900 $826,000
Q4 2020

Nov 12, 2021

BUY
$105.0 - $114.42 $231,000 - $251,724
2,200 New
2,200 $240,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.